Our Patient-first AI mission is to create medicines with improved probability of success.
Combining high-precision information from viable patient tissue, screened in our own laboratories, with our carefully engineered CentaurAI systems, empowers target selection, precision design & experiment, as well as enhanced clinical assessment.
We use patient tissue data to define optimal profiles for research, improve experimental assessment during design and improve outcomes in a medical setting.
Drug discovery is precision engineering at the molecular scale. Exscientia's team is delivering key advances across data acquisition, Machine Learning and Generative systems to fulfil sophisticated design objectives
Talented teams define projects and set strategic goals, while allowing AI systems to achieve tactical excellence across preclinical and clinical research